MÄRKL, Florian, SCHULTHEISS, Christoph, ALI, Murtaza, CHEN, Shih-Shih, ZINTCHENKO, Marina, EGLI, Lukas, MIETZ, Juliane, CHIJIOKE, Obinna, PASCHOLD, Lisa, SPAJIC, Sebastijan, HOLTERMANN, Anne, DÖRR, Janina, STOCK, Stephanie, ZINGG, Andreas, LÄUBLI, Heinz, PISEDDU, Ignazio, ANZ, David, MINDEN, Marcus Dühren-von, ZHANG, Tianjiao, NERRETER, Thomas, HUDECEK, Michael, MINGUET, Susana, CHIORAZZI, Nicholas, KOBOLD, Sebastian und BINDER, Mascha, 2024. Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Freiburg: Universität.

Märkl, F., Schultheiß, C., Ali, M., Chen, S.-S., Zintchenko, M., Egli, L., Mietz, J., Chijioke, O., Paschold, L., Spajic, S., Holtermann, A., Dörr, J., Stock, S., Zingg, A., Läubli, H., Piseddu, I., Anz, D., Minden, M.D.- von, Zhang, T., Nerreter, T., Hudecek, M., Minguet, S., Chiorazzi, N., Kobold, S., Binder, M., 2024. Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Universität, Freiburg. https://doi.org/10.1038/s41467-024-45378-w

Märkl, F., Schultheiß, C., Ali, M., Chen, S.-S., Zintchenko, M., Egli, L., Mietz, J., Chijioke, O., Paschold, L., Spajic, S., Holtermann, A., Dörr, J., Stock, S., Zingg, A., Läubli, H., Piseddu, I., Anz, D., Minden, M. D.- von, Zhang, T., Nerreter, T., Hudecek, M., Minguet, S., Chiorazzi, N., Kobold, S., & Binder, M. (ca. 2024). Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia [Cd]. Universität. https://doi.org/10.1038/s41467-024-45378-w

Märkl F, Schultheiß C, Ali M, Chen S-S, Zintchenko M, Egli L, Mietz J, Chijioke O, Paschold L, Spajic S, Holtermann A, Dörr J, Stock S, Zingg A, Läubli H, Piseddu I, Anz D, Minden MD- von, Zhang T, Nerreter T, Hudecek M, Minguet S, Chiorazzi N, Kobold S, Binder M (2024) Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia. Universität, Freiburg

Märkl, Florian/ Schultheiß, Christoph/ Ali, Murtaza/ Chen, Shih-Shih/ Zintchenko, Marina/ Egli, Lukas/ Mietz, Juliane/ Chijioke, Obinna/ Paschold, Lisa/ Spajic, Sebastijan/ Holtermann, Anne/ Dörr, Janina/ Stock, Stephanie/ Zingg, Andreas/ Läubli, Heinz/ Piseddu, Ignazio/ Anz, David/ Minden, Marcus Dühren-von/ Zhang, Tianjiao/ Nerreter, Thomas/ Hudecek, Michael/ Minguet, Susana/ Chiorazzi, Nicholas/ Kobold, Sebastian/ Binder, Mascha, Mutation-specific CAR T cells as precision therapy for IGLV3-21 R110 expressing high-risk chronic lymphocytic leukemia, Freiburg 2024.